奥西默替尼
医学
肺癌
肿瘤科
内科学
二线治疗
癌症研究
直线(几何图形)
癌症
表皮生长因子受体
化疗
几何学
数学
埃罗替尼
作者
Byoung Chul Cho,Hidetoshi Hayashi,Jong-Seok Lee,Se-Hoon Lee,Pongwut Danchaivijitr,Ying Cheng,Baogang Liu,Adlinda Alip,Hailin Xiong,Soon Hin How,Gee‐Chen Chang,James Chih‐Hsin Yang,Hiroshige Yoshioka,Mehmet Alı Nahıt Şendur,Kumar Prabhash,Koichi Azuma,Yun-Gyoo Lee,Chien‐Chung Lin,Shingo Matsumoto,Patrapim Sunpaweravong
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2025-03-15
卷期号:204: 108496-108496
被引量:4
标识
DOI:10.1016/j.lungcan.2025.108496
摘要
Amivantamab-lazertinib demonstrated superior progression-free survival versus osimertinib in Asian participants, with a tolerable safety profile. These results were consistent with those in the overall population.
科研通智能强力驱动
Strongly Powered by AbleSci AI